Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 105,446 | 125,512 | 168,982 | 294,270 |
| Receivables | N/A | 6,154 | 7,865 | 6,559 | 12,581 |
| Inventories | N/A | 12,633 | 10,542 | 8,061 | 20,942 |
| Other current assets | 0 | 342,024 | 385,325 | 122,949 | 63,317 |
| TOTAL | $N/A | $495,548 | $551,256 | $313,895 | $406,889 |
| Non-Current Assets | |||||
| PPE Net | N/A | 3,039 | 3,264 | 2,560 | 6,576 |
| Investments And Advances | 0 | 0 | 70,933 | 0 | 67,200 |
| Intangibles | 0 | 12,550 | 12,884 | 13,186 | 361,292 |
| Other Non-Current Assets | 0 | 9,519 | 21,466 | 387,565 | 23,188 |
| TOTAL | $N/A | $25,108 | $108,547 | $403,311 | $458,256 |
| Total Assets | $N/A | $520,656 | $659,803 | $717,206 | $865,145 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 3,524 | 5,229 | 2,675 | 13,256 |
| Other current liabilities | N/A | 18,213 | 24,554 | 31,095 | N/A |
| TOTAL | $N/A | $36,235 | $41,742 | $45,693 | $40,926 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 64,777 | 65,234 | 78,175 | 186,967 |
| TOTAL | $N/A | $64,420 | $64,946 | $78,235 | $186,785 |
| Total Liabilities | $N/A | $100,655 | $106,688 | $123,928 | $227,711 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,516 | 113,982 | 116,547 | 123,592 | 114,185 |
| Common Shares | N/A | 1,139 | 1,205 | 1,243 | 1,142 |
| Retained earnings | N/A | 485,493 | 621,131 | 670,832 | 736,695 |
| Other shareholders' equity | 0 | -467 | -354 | 78 | 16 |
| TOTAL | $N/A | $420,001 | $553,115 | $593,278 | $637,434 |
| Total Liabilities And Equity | $0 | $520,656 | $659,803 | $717,206 | $865,145 |